Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Best Cosmetic Surgery and Aesthetics Stocks to Buy

In this article, we discuss 10 best cosmetic surgery and aesthetics stocks to buy. If you want to skip our detailed discussion on the cosmetics and aesthetics sector, head directly to 5 Best Cosmetic Surgery and Aesthetics Stocks to Buy.

The American Society of Plastic Surgeons noted that numerous celebrities adopted a perspective favoring larger proportions through plastic surgery, where fuller breast and buttock sizes became the preferred aesthetic. However, there appears to be a shift in this trend in 2023. If really bold changes from plastic surgery are becoming less popular, they are being swapped for a more natural and authentic look in general. Dr. Ashley Amalfi, MD, who specializes in procedures for the breasts and body, has pointed out this change. Apart from the growing preference for a natural appearance, there are additional plastic surgery treatments that are becoming popular this year. Liposuction remains consistently trending, yet Amalfi has noticed a recent influx of patients seeking a distinct and tailored liposuction technique. She has shaped specific areas, like the lower part of the leg and the ankle, as per her patients’ requests. In addition to surgery, nonsurgical procedures remain popular in 2023. ASPS President Gregory Greco, DO, FACS, stated:

“People are influenced by influencers. And I think we’re seeing the more subtle, understated aesthetic in many celebrities.”

Don’t Miss: 12 Countries That Produce The Best Cosmetics

According to Forbes, a report from 2021 about cosmetic surgeries and treatments in North America predicted that the market would keep growing steadily, increasing at a compound annual growth rate (CAGR) of around 6.34% between 2021 and 2028. This number is on track to becoming a reality. Hollywood has often been seen as a major driving force behind the cosmetic surgery field. The fact that numerous celebrities have chosen cosmetic procedures to improve their appearance has naturally influenced others to do the same. One positive outcome of this trend is that it is gradually reducing the negative opinions often associated with cosmetic surgeries. As the field of cosmetic surgery continues to thrive, there have been significant advancements in technology for improving the quality of procedures. This progress is noticeable in the adoption of advanced tools like ultrasonic saws for different cosmetic treatments. The market is increasingly being linked with the fashion and beauty sector, even more than the medical field. Although cosmetic surgeries are accessible to everyone, 94% of procedures are sought by women. Furthermore, 43% of college-age individuals have expressed their readiness to consider more surgeries in the future. Cosmetic surgery is known for its relatively higher costs. Reports highlight that procedures like facelifts can begin at around $8000, excluding facility and additional expenses. However, the expense trend for cosmetic surgeries is shifting. The cost of procedures is decreasing mainly due to the increased number of available cosmetic surgeons and alternative treatments. Dr. Ali Esmail, an esteemed specialist in facial plastic reconstruction surgery, observed that this change is a direct response to the growing cultural acceptance of cosmetic surgeries. He commented:

“Cosmetic surgeries are no longer such a taboo, it has become a popular option for people who want to improve their looks or well-being. The regularity means more demand and more supply, which affects cost.”

According to Alliance Cosmetic Center, surgical enhancements for beauty have become a widespread practice worldwide, with the global cosmetic surgery market anticipated to reach $43.9 billion by 2025. Notably, around 20% of all cosmetic procedures take place in the United States. The American Society of Plastic Surgeons (ASPS) noted a 200% rise in non-invasive treatments such as botox and dermal fillers since 2000, with millennials showing the most interest. Such procedures are becoming increasingly popular in the United Kingdom. Dr. Jonquille Chantrey, a cosmetic surgeon and international aesthetic lecturer, stated:

“Non-invasive procedures continue to rise in the UK far more than any other sector. People want comparable surgical results but without the risks and downtime. Botox remains extremely popular, but I’m seeing a huge increase in non-invasive body contouring and fat removal through machines such as CoolSculpting.”

Also Read: 14 Best Beauty Stocks To Buy Now

Fortune Business Insights reported that in 2022, the worldwide market for cosmetic surgery was worth $55.68 billion. This value is expected to rise from $57.67 billion in 2023 to about $75.20 billion by the year 2030. This growth reflects a compound annual growth rate (CAGR) of 3.9% over the forecast period. Every year, more and more people are turning to cosmetic procedures to enhance their looks. Additionally, the rise in dermatological issues and a substantial number of patients in need of treatment are driving up the demand for these procedures in the market. In addition to a number of patients going through surgeries, many people are now opting for simple and painless methods to achieve a youthful and healthy look without any issues. This trend is leading to a higher demand for non-surgical procedures. The COVID-19 pandemic led to a decrease in the global demand for cosmetic procedures. However, the market is expected to experience growth from 2023 to 2030 due to the relaxation of lockdown measures, a rising interest in home care procedures, and a focus on introducing advanced products to cater to this demand.

To benefit from the growth potential in the fields of cosmetic surgery and aesthetics, some of the best stocks to buy include Zimmer Biomet Holdings, Inc. (NYSE:ZBH), InMode Ltd. (NASDAQ:INMD), and Cutera, Inc. (NASDAQ:CUTR). 

Our Methodology 

We selected the following aesthetics stocks based on hedge fund sentiment toward each stock. We have assessed the hedge fund sentiment from Insider Monkey’s database of 910 elite hedge funds tracked as of the end of the second quarter of 2023. The list is arranged in ascending order of the number of hedge fund investors in each firm. 

Poznyakov/Shutterstock.com

Best Cosmetic Surgery and Aesthetics Stocks to Buy

10. Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH)

Number of Hedge Fund Holders: 1

Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) delivers aesthetic medical services in both the People’s Republic of China and Singapore. Their services include a range of surgical aesthetic procedures like eye surgery, rhinoplasty, breast augmentation, and liposuction. Additionally, the company offers non-surgical aesthetic treatments, as well as other aesthetic medical services. Established in 1997, the company is headquartered in Shenzhen, China. On May 17, Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) announced a Q1 GAAP EPS of $0.0006 and a revenue of $21.7 million.

According to Insider Monkey’s second quarter database, 1 hedge fund was bullish on Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH), same as the last quarter. Jim Simons’s Renaissance Technologies held 13,000 shares of the company worth $14,000.

In addition to Zimmer Biomet Holdings, Inc. (NYSE:ZBH), InMode Ltd. (NASDAQ:INMD), and Cutera, Inc. (NASDAQ:CUTR), Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) is one of the best aesthetics stocks to buy. 

9. Sientra, Inc. (NASDAQ:SIEN)

Number of Hedge Fund Holders: 3

Sientra, Inc. (NASDAQ:SIEN), one of the best aesthetics stocks to buy, is a company specializing in medical aesthetics. It creates and markets medical aesthetic products both within the United States and globally. Its customer base includes hospitals, surgery centers, plastic surgeons, dermatologists, and other specialized medical fields. On August 10, Sientra, Inc. (NASDAQ:SIEN) reported a Q2 GAAP EPS of -$0.85, exceeding estimates by $0.03, and a revenue of $23.13 million, falling short of Wall Street consensus by $1.85 million.

According to Insider Monkey’s second quarter database, 3 hedge funds were bullish on Sientra, Inc. (NASDAQ:SIEN), compared to 5 hedge funds in the previous quarter. Israel Englander’s Millennium Management is the leading position holder in the company, with 25,777 shares worth $75,527.

8. Milestone Scientific Inc. (NYSE:MLSS)

Number of Hedge Fund Holders: 3

Next on our list of the best aesthetics stocks is Milestone Scientific Inc. (NYSE:MLSS), a company focused on the research and advancement of biomedical technology. It holds patents, designs, creates, and brings to market injection technologies and devices meant for medical, dental, and cosmetic purposes. These innovations are utilized in the United States, China, and globally. The company functions in two segments – Dental and Medical. On August 15, Milestone Scientific Inc. (NYSE:MLSS) reported a Q2 GAAP EPS of -$0.03, falling short of Wall Street estimates by $0.01. On a positive note, its revenue came in at $2.9 million, outperforming market expectations by $0.23 million.

According to Insider Monkey’s second quarter database, 3 hedge funds were bullish on Milestone Scientific Inc. (NYSE:MLSS). This number increased from the previous quarter when 1 fund was invested in Milestone Scientific Inc. (NYSE:MLSS). Israel Englander’s Millennium Management is the largest stakeholder of the company, with 234,770 shares valued at $204,367.

7. So-Young International Inc. (NASDAQ:SY)

Number of Hedge Fund Holders: 5

So-Young International Inc. (NASDAQ:SY) manages a digital platform for accessing healthcare services in China and internationally. So-Young International Inc. (NASDAQ:SY)’s platform empowers individuals to explore information and exchange their own experience concerning medical aesthetic procedures. Furthermore, it guides users towards booking treatment services offered by providers of medical aesthetic services for in-person procedures. So-Young International Inc. (NASDAQ:SY) is one of the best cosmetic surgery and aesthetics stocks to buy. On August 21, So-Young International Inc. (NASDAQ:SY) announced a Q2 GAAP EPADS of $0.00 and a revenue of $56.8 million, up 33.3% year-over-year. 

According to Insider Monkey’s second quarter database, 5 hedge funds were long So-Young International Inc. (NASDAQ:SY), same as the prior quarter. Seth Fischer’s Oasis Management held the largest position in the company, with 2.5 million shares worth $4.6 million.

6. AirSculpt Technologies, Inc. (NASDAQ:AIRS)

Number of Hedge Fund Holders: 8

AirSculpt Technologies, Inc. (NASDAQ:AIRS) serves as a holding company for EBS Intermediate Parent LLC, which delivers body contouring procedure services within the United States. On August 11, AirSculpt Technologies, Inc. (NASDAQ:AIRS) announced a Q2 non-GAAP EPS of $0.13, falling short of Wall Street estimates by $0.02. The revenue increased 12.1% year-over-year to $55.7 million, in-line with market consensus. 

According to Insider Monkey’s second quarter database, 8 hedge funds were bullish on AirSculpt Technologies, Inc. (NASDAQ:AIRS), compared to 7 funds in the preceding quarter. Stephen White’s SW Investment Management is the leading stakeholder of the company, with 3.4 million shares valued at $29.4 million.

Like Zimmer Biomet Holdings, Inc. (NYSE:ZBH), InMode Ltd. (NASDAQ:INMD), and Cutera, Inc. (NASDAQ:CUTR), AirSculpt Technologies, Inc. (NASDAQ:AIRS) is one of the top aesthetics stocks to watch. 

Click to continue reading and see 5 Best Cosmetic Surgery and Aesthetics Stocks to Buy

Suggested articles:

Disclosure: None. 10 Best Cosmetic Surgery and Aesthetics Stocks to Buy is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…